Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Holter of Movement in Patients with Multiple Sclerosis. Acti-SEP Study: Uncontrolled Environment.

NCT04882891 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Liege as lead sponsor.

NCT NCT04882891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04882891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Holter of Movement in Patients with Multiple Sclerosis. Acti-SEP Study: Uncontrolled Environment.
Lead sponsor
Centre Hospitalier Universitaire de Liege
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 9, 2021
Completion date
February 15, 2026
Enrollment
80 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis